SkyOak Wealth LLC Has $1.32 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

SkyOak Wealth LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,504 shares of the healthcare conglomerate’s stock after acquiring an additional 45 shares during the quarter. SkyOak Wealth LLC’s holdings in UnitedHealth Group were worth $1,318,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp grew its holdings in UnitedHealth Group by 1.7% in the 2nd quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock valued at $22,260,241,000 after buying an additional 764,872 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares in the last quarter. Morgan Stanley grew its position in shares of UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after purchasing an additional 1,893,192 shares in the last quarter. Moneta Group Investment Advisors LLC grew its position in shares of UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares in the last quarter. Finally, Alliancebernstein L.P. grew its position in UnitedHealth Group by 3.5% during the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock worth $5,647,433,000 after buying an additional 399,739 shares in the last quarter. 85.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on UNH. Barclays began coverage on UnitedHealth Group in a report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 target price on the stock. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Friday, January 19th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $579.33.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.3 %

UnitedHealth Group stock traded down $1.68 during midday trading on Friday, reaching $490.01. The stock had a trading volume of 2,846,975 shares, compared to its average volume of 4,168,188. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The company has a market capitalization of $451.75 billion, a P/E ratio of 20.60, a PEG ratio of 1.35 and a beta of 0.54. The company has a fifty day moving average price of $505.61 and a two-hundred day moving average price of $518.05. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue was up 14.1% compared to the same quarter last year. During the same period in the previous year, the company posted $5.34 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.79 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.